This is the first time in our country that a group of experts in the field of hepatology gather to review the current status of HBV infection establishing the First National Consensus on Chronic Hepatitis B. With the new sensitive diagnostic methods, new antivirals capable of inhibiting viral replication, the appropriate use of passive and active immunoprophilaxis, and the better understanding of the natural history of the disease, we are finding new corners in the approach of high risk groups and management of infected patients. The National Consensus on Chronic Hepatitis B reunited 34 Mexican leaders in Hepatology, Gastroenterology, Infectology, Pediatrics, Oncology, Pathology and Molecular Biology. During these rounds the need of incorporating new knowledge on Hepatitis B in our daily clinical practice was analyzed in a way to transform Hepatitis B to an understandable and easy subject. Also, the fears on the knowledge of basic molecular biology, practical analysis of serologic markers, and diagnostic methodology as well as use and indications for new therapeutic agents was also discussed. This is a first consensus.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Revision of institutional accreditation standards and processes in Iranian medical universities.
J Educ Health Promot
November 2024
Medical Education Research Center, Department of Medical Education, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: The institutional accreditation standards were revised after the initial round of institutional accreditation and gaining experience while scrutinizing issues and complications. This research covers the steps needed to update and then compile the new standards, making the necessary changes in regulations, self-evaluation guides, external evaluation, ethics, and the required forms.
Materials And Methods: This comprehensive developmental study, conducted in two main phases from 2019 to 2022 at Isfahan University of Medical Sciences, employed a variety of rigorous methods.
Factors associated with willingness to perform expedited excisional treatment for patients at high risk for cervical precancer.
Gynecol Oncol Rep
February 2025
H. Lee Moffitt Cancer Center & Research Institute, Health Outcomes and Behavior, Tampa, FL, United States.
Background: The 2019 ASCCP Risk-Based Management Consensus Guidelines prefer expedited treatment, defined as proceeding to excisional treatment without first performing colposcopic biopsy, for patients with screening results indicating a high risk of cervical precancer. In this mixed methods study, we explored clinician attitudes toward expedited treatment.
Methods: In 2021, a national sample of 671 clinicians who performed colposcopy completed surveys; a subset (n = 41) of clinicians who performed colposcopy and/or directed patient treatment completed qualitative interviews.
Evidence summary on management strategies for gastroesophageal reflux symptoms in patients following esophageal cancer surgery.
Asia Pac J Oncol Nurs
December 2025
Esophageal Oncology Department, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Objective: This study aimed to summarize evidence-based strategies for the self-management of gastroesophageal reflux symptoms (GERS) at home among patients who have undergone esophageal cancer surgery, providing practical references for clinical practice.
Methods: A systematic evidence summary was conducted based on the reporting standards of the Fudan University Center for Evidence-based Nursing. Literature was retrieved from international and Chinese databases, including guidelines, expert consensus, systematic reviews, and original studies.
A scoping review of the reporting quality of reviews of commercially and publicly available mobile health apps.
JAMIA Open
February 2025
Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester M13 9PL, United Kingdom.
Objectives: There is no guidance to support the reporting of systematic reviews of mobile health (mhealth) apps (app reviews), so authors attempt to use/modify the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). There is a need for reporting guidance, building on PRISMA where appropriate, tailored to app reviews. The objectives were to describe the reporting quality of published mHealth app reviews, identify the need for, and develop potential candidate items for a reporting guideline.
View Article and Find Full Text PDFBackground And Aims: Neonatal sepsis is a major cause of neonatal mortality worldwide. It remains a detrimental bottleneck to the WHO goal of eradicating preventable deaths for children below 5 years of age by 2030. Though the risk factors for adverse clinical outcomes for neonatal sepsis have been widely studied there is no universal consensus.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!